Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSChenodeoxycholic acid (CRM) (Item No. 44867) is a certified reference material categorized as a primary bile acid.1 Decreased serum levels of chenodeoxycholic acid (CDCA) are associated with ulcerative colitis.2 Serum levels of CDCA decrease in patients who are no longer diabetic following gastric bypass surgery.3 Formulations containing chenodeoxycholic acid have been used in the treatment of cerebrotendinous xanthomatosis (CTX). This product is intended for use in quantitative analytical research applications. This product is also available as a general research tool (Item Nos. 10011286 | 35346).
WARNING This product is not for human or veterinary use.
1. Chenodeoxycholic acid: An update on its therapeutic applications. Bile acids and their receptors. Handbook of experimental pharmacology 256, 265-282 (2019).
2. Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. World J. Gastroenterol. 15(25), 3134-3141 (2009).
3. Chenodeoxycholic acid as a potential prognostic marker for Roux-